Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296

Glenmark Pharma Live Share Price Today, Share Analysis and Chart

Mid-range Performer

In 2 Starfolio Baskets

Iran war impact

The impact of the Iran-Israel conflict on Glenmark Pharmaceuticals Ltd. (GLENMARK) is categorized as minimal to low negative, primarily driven by indirect supply chain pressures rather than significant direct revenue exposure. While the company h...

2170.50 2.00 (0.09%)

62.46% Gain from 52W Low

785.6K

NSE+BSE Volume

NSE 27 Mar, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

58.7 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

1Yr Price target upside is 2%

Glenmark Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Glenmark Pharmaceuticals Ltd. worth buying?

581 Votes:

Buy 79.52%

Sell 13.6%

Hold 6.88%